Bollard Group LLC Portfolio Holdings

Bollard Group LLC

  • $4.37 Billion
  • Q2 2025

Bollard Group LLC has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $4.37 Billion distributed in 295 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Boston Scientific Corp with a value of $2.16B, Eli Lilly & CO with a value of $196M, Amazon Com Inc with a value of $171M, Spdr S&P 500 ETF Tr Call Optio with a value of $158M, and Microsoft Corp with a value of $157M.

Examining the 13F form we can see an increase of $566M in the current position value, from $3.81B to 4.37B. Also it can be appreciated an additional of 26 stocks purchases and 1 closed positions.

Bollard Group LLC is based out at Boston, MA

Below you can find more details about Bollard Group LLC portfolio as well as his latest detailed transactions.

Portfolio value $4.37 Billion
Healthcare: $2.44 Billion
Technology: $367 Million
Energy: $294 Million
Consumer Cyclical: $203 Million
Utilities: $191 Million
Industrials: $175 Million
Financial Services: $159 Million
Communication Services: $145 Million
Other: $228 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$58.4B
$356,000 0.01% of portfolio
4,162
Q2 2025 Added 5.55%
$79.7B
$466,000 0.01% of portfolio
1,107
Q2 2025 Added 5.33%
$36.3B
$224,000 0.01% of portfolio
3,178
Q2 2025 Added 5.76%
$69B
$522,000 0.01% of portfolio
4,951
Q2 2025 Added 3.77%
$1.16B
$440,000 0.01% of portfolio
27,131
Q4 2021 New
$644B
$321,000 0.01% of portfolio
660
Q2 2023 Added 32.0%
$21.4B
$448,000 0.01% of portfolio
20,192
Q2 2025 Reduced 28.54%
Canadian Pacific Kansas City C
-
$484,000 0.01% of portfolio
-
Q2 2025 Added 0.15%
$113B
$388,000 0.01% of portfolio
1,340
Q2 2025 Added 3.88%
$24.6B
$431,000 0.01% of portfolio
2,891
Q2 2025 Added 3.88%
$23.2B
$297,000 0.01% of portfolio
9,340
Q2 2025 Reduced 34.74%
$232B
$236,000 0.01% of portfolio
800
Q3 2023 Reduced 1.23%
$42.9B
$456,000 0.01% of portfolio
10,496
Q2 2025 Added 0.83%
$2.49B
$459,000 0.01% of portfolio
44,140
Q1 2023 New
$41B
$313,000 0.01% of portfolio
2,946
Q2 2025 Added 6.01%
$29.2B
$365,000 0.01% of portfolio
7,042
Q2 2025 Added 4.64%
$50.8B
$376,000 0.01% of portfolio
5,040
Q2 2025 Added 1.63%
$89.3B
$264,000 0.01% of portfolio
904
Q2 2025 Added 5.61%
$73.7B
$635,000 0.01% of portfolio
14,042
Q2 2025 Reduced 4.61%
$45.5B
$350,000 0.01% of portfolio
1,000
Q2 2025 New
$0
$494,000 0.01% of portfolio
800
Q4 2023 Reduced 70.99%
$1.38B
$300,000 0.01% of portfolio
25,609
Q4 2024 Reduced 46.88%
$18.3B
$587,000 0.01% of portfolio
10,062
Q2 2025 Added 5.3%
$61.4B
$445,000 0.01% of portfolio
4,409
Q2 2025 Added 3.35%
$278B
$420,000 0.01% of portfolio
6,054
Q2 2025 Added 5.53%
$14.1B
$3,000 0.0% of portfolio
85
Q2 2025 Reduced 99.87%
$173B
$61,000 0.0% of portfolio
1,000
Q3 2023 Added 148.76%
$49.3B
$141,000 0.0% of portfolio
4,163
Q2 2025 Added 5.05%
$76.9B
$151,000 0.0% of portfolio
979
Q2 2025 Added 5.38%
$50.9B
$1,000 0.0% of portfolio
8
Q4 2023 Reduced 83.33%
$2.36B
$1,000 0.0% of portfolio
20
Q2 2025 Reduced 99.63%
$6.96B
$1,000 0.0% of portfolio
25
Q3 2023 New
$92.4B
$60,000 0.0% of portfolio
137
Q1 2025 Added 0.74%
$0
$11,000 0.0% of portfolio
123
Q2 2025 Added 0.82%
$1.57B
$9,000 0.0% of portfolio
2,112
Q1 2018 Reduced 1.95%
$5.77B
$0 0.0% of portfolio
16
Q2 2022 Reduced 98.57%
$177M
$1,000 0.0% of portfolio
175
Q2 2025 Reduced 98.77%
$13.3B
$21,000 0.0% of portfolio
64
Q3 2022 Reduced 98.58%
$4.71B
$5,000 0.0% of portfolio
47
Q2 2025 Added 2.17%
$7.18B
$23,000 0.0% of portfolio
611
Q4 2022 Added 0.16%
$60.2B
$202,000 0.0% of portfolio
4,704
Q2 2025 Added 6.38%
$0
$118,000 0.0% of portfolio
1,755
Q2 2025 Added 0.75%
$0
$91,000 0.0% of portfolio
1,121
Q2 2025 Added 0.36%
$0
$49,000 0.0% of portfolio
576
Q2 2025 Added 19.5%
$41.8B
$92,000 0.0% of portfolio
1,209
Q2 2025 Added 5.77%
Soleno Therapeutics Inc
-
$192,000 0.0% of portfolio
-
Q4 2022 New
$58.6M
$90,000 0.0% of portfolio
55,555
Q1 2021 New
$11.6B
$50,000 0.0% of portfolio
741
Q2 2025 Added 6.31%
$0
$37,000 0.0% of portfolio
626
Q2 2025 Added 0.64%

Summary

  • Portfolio
  • No. of Stocks 295
  • Current Value $4.37 Billion
  • Prior Value $3.81 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 13, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 26 stocks
  • Additional Purchases 197 stocks
  • Sold out of 1 stocks
  • Reduced holdings in 19 stocks
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email